Pharma - HealthQuill

Gram-negative, Chlamydia psittaci bacteria

Invasive fungal infections on the rise

HQ Team October 26, 2023: While athlete’s foot and yeast infections are well-known, a new threat is emerging from invasive fungal infections, which.

by HealthQuill
October 26, 2023
0 Comments

Drugs Health Medical Pharma

Revolutionary device decodes RNA for faster diagnosis of cancer

HQ Team October 26, 2023: Scientists at the University of Notre Dame have developed an innovative device that can decode the messages exchanged.

by HealthQuill
October 26, 2023
0 Comments

The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.

Drugs Health Pharma

BioMarin’s achondroplasia drug gets nod for children of all ages

HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.

by HealthQuill
October 21, 2023
0 Comments

The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years and 25 years.

Drugs Health Pharma

Pfizer’s vaccine for meningococcal disease gets FDA approval

HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years.

by HealthQuill
October 21, 2023
0 Comments

Experiments conducted on young adult rats have established a link between Alzheimer’s and gut microbiota, according to a global study.

Drugs Health Pharma

Scientists connect gut microbiota to Alzheimer’s disease in lab experiments

HQ Team October 19, 2023: Experiments conducted on young adult rats have established a link between Alzheimer’s and gut microbiota, according to a.

by HealthQuill
October 19, 2023
2 Comments

Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative pain treatment drug.

Drugs Health Pharma

Belgium’s Hyloris gets nod for post-operative pain reduction drug

HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative.

by HealthQuill
October 18, 2023
0 Comments

Drugs Health Pharma

Novo Nordisk to buy hypertension drug from KBP for $1.3 billion

HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.

by HealthQuill
October 16, 2023
0 Comments

Germany's BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty vaccine may impact 2023 revenue of up to $900 million.

Drugs Health Pharma

BioNTech expects revenue to be lower in 2023 as Covid-19 vaccine sales fall

HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty.